Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IGM Biosciences, Inc. | Chief Executive Officer, Director | Common Stock | 349K | $4.02M | $11.54 | Oct 2, 2024 | Direct |
IGM Biosciences, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 370K | Oct 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IGMS | IGM Biosciences, Inc. | Oct 2, 2024 | 2 | $0 | 4 | Oct 4, 2024 | Chief Executive Officer, Director |
IGMS | IGM Biosciences, Inc. | Sep 13, 2024 | 1 | -$17.2K | 4 | Sep 17, 2024 | Head, Research & Autoimmunity |
IGMS | IGM Biosciences, Inc. | Jul 19, 2024 | 3 | $0 | 4 | Jul 23, 2024 | Head, Research & Autoimmunity |
IGMS | IGM Biosciences, Inc. | Jun 14, 2024 | 1 | -$11.9K | 4 | Jun 18, 2024 | Head, Research & Autoimmunity |
IGMS | IGM Biosciences, Inc. | Apr 14, 2024 | 0 | $0 | 3 | Apr 23, 2024 | Head, Research & Autoimmunity |